908 Devices (MASS) Net Income towards Common Stockholders (2020 - 2026)
908 Devices (MASS) posted quarterly Net Income towards Common Stockholders of -$14.9 million for Q1 2026, down 127.84% year-over-year from $53.4 million in Q1 2025, and down 7192.65% quarter-over-quarter from -$204000.0 in Q4 2025.
908 Devices (MASS) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends
908 Devices (MASS) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$14.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 127.84% year-over-year to -$14.9 million; the TTM figure through Mar 2026 stood at -$15.6 million (down 139.47% YoY), while the FY2025 annual figure was $52.8 million, up 376.75% from the prior year.
- Net Income towards Common Stockholders eased to -$14.9 million in Q1 2026 per MASS's latest filing, from -$204000.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $53.4 million in Q1 2025 and bottomed at -$14.9 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged -$3.1 million across 5 years, with a median of -$6.3 million in 2022.
- Annual changes were most pronounced in 2025 — Net Income towards Common Stockholders soared 1164.12% — and 2026, when it sank 127.84%.
- 908 Devices' Net Income towards Common Stockholders stood at -$9.8 million in 2022, then rose by 24.12% to -$7.4 million in 2023, then soared by 53.94% to -$3.4 million in 2024, then jumped by 94.04% to -$204000.0 in 2025, then plunged by 7192.65% to -$14.9 million in 2026.
- Business Quant data shows MASS's Net Income towards Common Stockholders at -$14.9 million in Q1 2026, -$204000.0 in Q4 2025, and -$72000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | 908 Devices | 387.46 Mn | 285.93 Mn | 8.34 Mn | -11.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.89 Mn |
| Mar 31, 2026 | -14.88 Mn |
| Dec 31, 2025 | -204,000.00 |
| Sep 30, 2025 | -72,000.00 |
| Jun 30, 2025 | -398,000.00 |
| Mar 31, 2025 | 53.44 Mn |
| Dec 31, 2024 | -3.42 Mn |
| Sep 30, 2024 | -5.65 Mn |
| Jun 30, 2024 | -4.98 Mn |
| Mar 31, 2024 | -5.02 Mn |
| Dec 31, 2023 | -7.43 Mn |
| Sep 30, 2023 | -7.09 Mn |
| Jun 30, 2023 | -9.35 Mn |
| Mar 31, 2023 | -12.53 Mn |
| Dec 31, 2022 | -9.79 Mn |
| Sep 30, 2022 | -6.26 Mn |
| Jun 30, 2022 | -8.10 Mn |
| Mar 31, 2022 | -10.68 Mn |
| Dec 31, 2021 | -7.42 Mn |
| Sep 30, 2021 | -5.19 Mn |